Difference in effect of oral isotretinoin in combination with intralesional MMR and intralesional MMR alone in extragenital cutaneous warts: A randomized clinical trial
Phase 3
- Conditions
- Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
- Registration Number
- CTRI/2024/06/069158
- Lead Sponsor
- AIIMS Jodhpur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Clinical diagnosis of warts.
2. Patient having 5 or more warts.
3. Age 14 – 60 years.
4. No topical treatment in last 2 weeks and systemic treatment in previous 4 weeks.
Exclusion Criteria
1. Known hypersensitivity to vaccine or its component or isotretinoin.
2. Pregnant and lactating female.
3. Known case of-HIV, hepatitis B, hepatitis C.
4. Immunocompromised patients.
5. Patient having chronic liver disease, kidney disease or systemic illness.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method